Palisade Bio

-$0.0381 (-7.19%) Today
+$0.0181 (+3.68%) As of 8:23 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Palisade Bio and other ETFs, options, and stocks.

About PALI

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery.

CEO
Thomas M. Hallam
Employees
13
Headquarters
Carlsbad, California
Founded
2011

PALI Key Statistics

Market cap
10.76M
Price-Earnings ratio
—
Dividend yield
—
Average volume
221.54K
High today
$0.5141
Low today
$0.4801
Open price
$0.5141
Volume
71.43K
52 Week high
$4.57
52 Week low
$0.40

PALI Earnings

-$0.79
-$0.28
$0.23
$0.74
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.26 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure